taldefgrobep alfa (BHV-2000) / BMS, Roche, Biohaven 
Welcome,         Profile    Billing    Logout  

1 Trials

   Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
taldefgrobep alfa (BHV-2000) / Biohaven
RESILIENT, NCT05337553 / 2022-000193-25: A Study to Evaluate the Efficacy and Safety of Taldefgrobep Alfa in Participants With Spinal Muscular Atrophy

Active, not recruiting
3
269
Europe, US, RoW
taldefgrobep alfa, BHV-2000, BMS-986089, Placebo
Biohaven Pharmaceuticals, Inc., Biohaven Pharmaceuticals, Inc, Biohaven Pharmaceuticals, Inc.
Spinal Muscular Atrophy, Neuromuscular Diseases, SMA
01/25
01/25

Download Options